Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.
source https://www.sciencedaily.com/releases/2025/02/250205130931.htm
After market tumult, Trump exempts smartphones from massive new tariffs
-
The Trump administration has excluded smartphones and other consumer
electronics from its steep “reciprocal” tariffs in a significant boost for
Big Tech ...
6 hours ago
No comments:
Post a Comment